IP Library Granted Patent US 12,201,405
Granted Patent B2
US 12,201,405 · App. 14/885,891 · Granted Jan 21, 2025

Assessing effectiveness of CPR

Inventors: Isobel Jane Mulligan (Niwot, CO); Gregory Zlatko Grudic (Niwot, CO); Steven L. Moulton (Littleton, CO)
Assignees: Flashback Technologies, Inc.; The Regents of the University of Colorado, a body corporate
A61B5/02042A61B5/02028A61B5/0205A61B5/02108A61B5/4848A61B5/4875A61B5/7275A61H31/00G16H50/20G16H50/50A61B5/002A61B5/02241A61B5/029A61B5/031A61B5/14551A61B5/318A61B5/369A61B5/398A61B5/4836A61B5/6826A61B5/7246A61B5/7267A61B5/742A61B7/04A61B2562/0219A61M1/1613G16H40/20G16H40/63
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,201,405
App. No.
14/885,891
Granted
Jan 21, 2025
Kind
B2
Abstract

Novel tools and techniques are provided for assessing, predicting and/or effectiveness of cardiopulmonary resuscitation (“CPR”), in some cases, noninvasively. In various embodiments, tools and techniques are provided for implementing rapid estimation of a patient's compensatory reserve index (“CRI”) before, during, and after CPR is performed, and using the CRI and variations in CRI values to determine, in some instances, in real-time, the effectiveness of CPR that is performed.

Claims (83)

1. A method for non-invasively determining the effectiveness of cardiopulmonary resuscitation (CPR) on a patient, comprising:

retrieving, by one or more computer systems, physiological data of the patient from one or more sensors monitoring the patient during CPR, wherein the physiological data is waveform data;

transforming, by one or more computer systems, the physiological data from waveform data to one or more patient compensatory serve index (“CRI”) values thereby transforming the waveform data to a numerical value, wherein transforming the physiological data to the one or more patient CRI values includes:

accessing a data store and acquiring a plurality of reference waveforms from a model, wherein each waveform of the plurality of reference waveforms corresponds to a respective CRI value determined from a ratio of intravascular volume loss at time t and intravascular volume loss at hemodynamic decompensation;

comparing the patient waveform data against the plurality of reference waveforms of the model;

determining a similarity between patient waveform data and the plurality of reference waveforms of the model individually; and

determining the one or more patient CRI values that corresponds to the patient waveform data based at least in part on respective similarities of the patient waveform data to each of the plurality of reference waveforms of the model;

based at least in part on the one or more patient CRI values, estimating, by one or more computer systems, an effectiveness of CPR on the patient, wherein the one or more patient CRI values are compared against a CRI model configured to relate changes in CRI values to the effectiveness of CPR on the patient; and

displaying, by one or more computer systems, the effectiveness of CPR on the patient on a user interface.

2. The method of claim 1 , wherein the one or more patient CRI values are estimated based on physiological data that are at least one of received before, received during, or received after CPR.

3. The method of claim 1 , wherein the one or more patient CRI values comprise a plurality of patient CRI values, and wherein estimating effectiveness of a CPR procedure on the patient further is based at least in part on an average value of CRI over a time period or a standard deviation of at least some of the plurality of patient CRI values, a skewness of at least some of the plurality of patient CRI values, a rate of change of at least two of the plurality of patient CRI values, or a difference between two of the plurality of values of CRI.

4. The method of claim 1 , wherein the effectiveness of CPR on the patient is displayed as a number on a scale from 0 to 100.

5. The method of claim 1 , wherein the plurality of reference waveforms of the model correspond to a state of hemodynamic decompensation or near hemodynamic decompensation, or a series of states progressing towards hemodynamic decompensation.

6. The method of claim 1 , wherein determining the similarity further comprises:

producing, for each respective patient waveform of the patient waveform data, a respective similarity coefficient representing a similarity between a respective patient waveform and each of the plurality of reference waveforms of the model;

normalizing the produced, respective similarity coefficients;

summing each respective value of CRI, corresponding to each of the plurality of reference waveforms of the model, respectively weighted by the normalized respective similarity coefficient; and

determining an estimated CRI value for the patient based on the summed, weighted CRI values.

7. The method of claim 1 , wherein at least one of the one or more sensors is selected from the group consisting of a blood pressure sensor, an intracranial pressure monitor, a central venous pressure monitoring catheter, an arterial catheter, an electroencephalograph, a cardiac monitor, a transcranial Doppler sensor, a transthoracic impedance plethysmograph, a pulse oximeter, a near infrared spectrometer, a ventilator, an accelerometer, and an electronic stethoscope.

8. The method of claim 1 , wherein the physiological data comprises data representing blood pressure waveforms, plethysmograph waveforms, or photoplethysmograph (PPG) waveforms.

9. The method of claim 1 , wherein the plurality of reference waveforms are generated by inducing a test subject to enter one or more physiological states, and obtaining physiological data from the test subject while the test subject is in a respective physiological state of the one or more physiological states.

10. The method of claim 9 , further comprising:

inducing a physiological state of reduced circulatory system volume in the test subject.

11. The method of claim 10 , wherein inducing the physiological state comprises subjecting the test subject to lower body negative pressure (“LBNP”).

12. The method of claim 11 , wherein inducing the physiological state comprises subjecting the test subject to dehydration.

13. The method of claim 9 , wherein the one or more physiological states comprises a state of cardiovascular collapse or near-cardiovascular collapse.

14. The method of claim 9 , wherein the one or more physiological states comprises a state of euvolemia.

15. The method of claim 9 , wherein the one or more physiological states comprises a state of hypervolemia.

16. The method of claim 9 , wherein the one or more physiological states comprises a state of dehydration or hypovolemia.

17. The method of claim 9 , further comprising correlating the physiological data of the test subject to the respective physiological state, wherein correlating the physiological data of the test subject with the respective physiological state of the test subject further comprises:

identifying a most predictive set of signals S k out of a set of signals s 1 , S 2 , . . . , S D for each of one or more outcomes o k , wherein the most-predictive set of signals S k corresponds to a first data set representing a first physiological parameter of the physiological data of the test subject, and wherein each of the one or more outcomes o k represents a physiological state measurement of the one or more physiological states respectively;

autonomously learning a set of probabilistic predictive models ô k =M k (S k ), where ô k is a prediction of outcome o k derived from a model M k that uses as inputs values obtained from the set of signals S k ; and

repeating the operation of autonomously learning incrementally from data that contains examples of values of signals s 1 , s 2 , . . . , s D and corresponding outcomes o 1 , o 2 , . . . , o K .

18. The method of claim 1 , wherein the effectiveness of CPR on the patient is displayed as a qualitative indicator.

19. The method of claim 1 , further including outputting instructions to control a therapeutic device.

20. A system for non-invasively assessing the health of a patient, comprising:

one or more sensors to obtain physiological data from the patient; and

a computer system in communication with the one or more sensors, the computer system comprising:

one or more processors; and

a non-transitory computer readable medium in communication with the one or more processors, the computer readable medium having encoded thereon a set of instructions executable by the one or more processors to cause the computer system to:

retrieve physiological data of the patient from one or more sensors monitoring the patient, wherein the physiological data is waveform data;

transform the physiological data from waveform data to one or more patient compensatory reserve index (“CRI”) values thereby transforming the waveform data to a numerical value, wherein transforming the physiological data to the one or more patient CRI values includes:

accessing a data store and acquiring a plurality of reference waveforms from a model, wherein each waveform of the plurality of reference waveforms corresponds to a respective CRI value determined from a ratio of intravascular volume loss at time t and intravascular volume loss at hemodynamic decompensation;

comparing the patient waveform data against the plurality of reference waveforms of the model;

determining a similarity between patient waveform data and the plurality of reference waveforms of the model individually; and

determining the one or more patient CRI values that corresponds to the patient waveform data based at least in part on respective similarities of the patient waveform data to each of the plurality of reference waveforms of the model;

based at least in part on the one or more patient CRI values, estimate the health of the patient, wherein the one or more patient CRI values are compared against a CRI model configured to relate changes in CRI values to the health of the patient; and

display the health of the patient on a user interface.

21. The system of claim 20 , wherein the one or more patient CRI values are estimated based on physiological data that are at least one of received before, received during, or received after CPR.

22. The system of claim 20 , wherein the one or more patient CRI values comprise a plurality of patient CRI values, and wherein estimating effectiveness of a CPR procedure on the patient further is based at least in part on an average value of CRI over a time period or a standard deviation of at least some of the plurality of patient CRI values, a skewness of at least some of the plurality of patient CRI values, a rate of change of at least two of the plurality of patient CRI values, or a difference between two of the plurality of values of CRI.

23. The system of claim 20 , further including displaying the effectiveness of CPR on the patient as a number on a scale from 0 to 100.

24. The system of claim 20 , wherein the plurality of reference waveforms of the model correspond to a state of hemodynamic decompensation or near hemodynamic decompensation, or a series of states progressing towards hemodynamic decompensation.

25. The system of claim 20 , wherein determining the similarity between patient waveform data and the plurality of reference waveforms of the model further comprises:

producing, for each respective patient waveform of the patient waveform data, a respective similarity coefficient representing the similarity between a respective patient waveform and each of the plurality of reference waveforms of the model;

normalizing the produced, respective similarity coefficients;

summing each respective value of CRI, corresponding to each of the plurality of reference waveforms of the model, respectively weighted by the normalized respective similarity coefficient; and

determining an estimated CRI value for the patient based on the summed, weighted CRI values.

26. The system of claim 20 , wherein at least one of the one or more sensors is selected from the group comprising of a blood pressure sensor, an intracranial pressure monitor, a central venous pressure monitoring catheter, an arterial catheter, an electroencephalograph, a cardiac monitor, a transcranial Doppler sensor, a transthoracic impedance plethysmograph, a pulse oximeter, a near infrared spectrometer, a ventilator, an accelerometer, and an electronic stethoscope.

27. The system of claim 20 , wherein the physiological data comprises data representing blood pressure waveforms, plethysmograph waveforms, or photoplethysmograph (PPG) waveforms.

28. The method of claim 20 , wherein the effectiveness of CPR on the patient is displayed as a qualitative indicator.

29. The method of claim 20 , further including outputting instructions to control a therapeutic device.

30. A system for non-invasively determining the effectiveness of cardiopulmonary resuscitation (CPR) on a patient, comprising:

one or more sensors to obtain physiological data from the patient; and

a computer system in communication with the one or more sensors, the computer system comprising:

one or more processors; and

a non-transitory computer readable medium in communication with the one or more processors, the computer readable medium having encoded thereon a set of instructions executable by the one or more processors to cause the computer system to:

retrieve physiological data of the patient from one or more sensors monitoring the patient during CPR, wherein the physiological data is waveform data;

transform the physiological data from waveform data to one or more patient compensatory reserve index (“CRI”) values thereby transforming the waveform data to a numerical value, wherein transforming the physiological data to the one or more patient CRI values includes:

accessing a data store and acquiring a plurality of reference waveforms from a model, wherein each waveform of the plurality of reference waveforms corresponds to a respective CRI value determined from a ratio of intravascular volume loss at time t and intravascular volume loss at hemodynamic decompensation;

comparing the patient waveform data against the plurality of reference waveforms of the model;

determining a similarity between patient waveform data and the plurality of reference waveforms of the model individually; and

determining the one or more patient CRI values that corresponds to the patient waveform data based at least in part on respective similarities of the patient waveform data to each of the plurality of reference waveforms of the model;

based at least in part on the one or more patient CRI values, estimate an effectiveness of CPR on the patient, wherein the one or more patient CRI values are compared against a CRI model configured to relate changes in CRI values to the effectiveness of CPR on the patient; and

display the effectiveness of CPR on the patient on a user interface.

31. The system of claim 30 , wherein the one or more patient CRI values comprise a plurality of patient CRI values, and wherein estimating effectiveness of a CPR procedure on the patient further is based at least in part on an average value of CRI over a time period or a standard deviation of at least some of the plurality of patient CRI values, a skewness of at least some of the plurality of patient CRI values, a rate of change of at least two of the plurality of patient CRI values, or a difference between two of the plurality of values of CRI.

32. The system of claim 30 , wherein determining the similarity between patient waveform data and the plurality of reference waveforms of the model further comprises:

producing, for each respective patient waveform of the patient waveform data, a respective similarity coefficient representing the similarity between a respective patient waveform and each of the plurality of reference waveforms of the model;

normalizing the produced, respective similarity coefficients;

summing each respective value of CRI, corresponding to each of the plurality of reference waveforms of the model, respectively weighted by the normalized respective similarity coefficient; and

determining an estimated CRI value for the patient based on the summed, weighted CRI values.

33. The system of claim 30 , wherein at least one of the one or more sensors is selected from the group comprising of a blood pressure sensor, an intracranial pressure monitor, a central venous pressure monitoring catheter, an arterial catheter, an electroencephalograph, a cardiac monitor, a transcranial Doppler sensor, a transthoracic impedance plethysmograph, a pulse oximeter, a near infrared spectrometer, a ventilator, an accelerometer, and an electronic stethoscope.

34. The system of claim 30 , wherein the physiological data comprises data representing blood pressure waveforms, plethysmograph waveforms, or photoplethysmograph (PPG) waveforms.

35. The method of claim 1 , further including outputting a recommended treatment option based on the one or more patient CRI values.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2016
From: MULLIGAN, ISOBEL JANE; GRUDIC, GREGORY ZLATKO
To: FLASHBACK TECHNOLOGIES, INC.
Reel/Frame 038912/0806 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2016
From: MOULTON, STEVEN L.
To: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Reel/Frame 038912/0818 →
Continuity (22)
Continuation In Part 14542426 · Nov 14, 2014
Continuation In Part 14542423 · Nov 14, 2014
Continuation In Part 14535171 · Nov 6, 2014
Continuation In Part 13554483 · Jul 20, 2012
Continuation In Part 13041006 · Mar 4, 2011
Continuation In Part 13028140 · Feb 15, 2011
Continuation In Part PCTUS2009062119 · Oct 26, 2009
Provisional Application 62064809 · Oct 16, 2014
Provisional Application 62064816 · Oct 16, 2014
Provisional Application 61905727 · Nov 18, 2013
Provisional Application 61904436 · Nov 14, 2013
Provisional Application 61900980 · Nov 6, 2013
Provisional Application 61614426 · Mar 22, 2012
Provisional Application 61510792 · Jul 22, 2011
Provisional Application 61310583 · Mar 4, 2010
Provisional Application 61305110 · Feb 16, 2010
Provisional Application 61252978 · Oct 19, 2009
Provisional Application 61166499 · Apr 3, 2009
Provisional Application 61166472 · Apr 3, 2009
Provisional Application 61166486 · Apr 3, 2009
Provisional Application 61109490 · Oct 29, 2008
Related Publication 20160038043A1 · Feb 11, 2016
References Cited (327)
US 4930517A · Cohen et al. · 1990 [cited by applicant]
US 5074310A · Mick · 1991 [cited by applicant]
US 5619990A · Kanai · 1997 [cited by examiner]
US 5853364A · Baker, Jr. et al. · 1998 [cited by applicant]
US 5865168A · Isaza · 1999 [cited by applicant]
US 5967981A · Watrous · 1999 [cited by applicant]
US 5984893A · Ward · 1999 [cited by applicant]
US 6083172A · Baker, Jr. et al. · 2000 [cited by applicant]
US 6094592A · Yorkey et al. · 2000 [cited by applicant]
US 6206830B1 · Diab et al. · 2001 [cited by applicant]
US 6248080B1 · Miesel · 2001 [cited by applicant]
US 6338713B1 · Chamoun et al. · 2002 [cited by applicant]
US 6371921B1 · Caro et al. · 2002 [cited by applicant]
US 6398728B1 · Bardy · 2002 [cited by applicant]
US 6409675B1 · Turcott · 2002 [cited by applicant]
US 6411833B1 · Baker, Jr. et al. · 2002 [cited by applicant]
US 6553991B1 · Isaza · 2003 [cited by applicant]
US 6556852B1 · Schulze · 2003 [cited by applicant]
US 6557553B1 · Borrello · 2003 [cited by applicant]
US 6558336B2 · Collins · 2003 [cited by applicant]
US 6589189B2 · Meyerson et al. · 2003 [cited by applicant]
US 6591122B2 · Schmitt · 2003 [cited by applicant]
US 6606509B2 · Schmitt · 2003 [cited by applicant]
US 6675031B1 · Porges et al. · 2004 [cited by applicant]
US 6721584B2 · Baker, Jr. et al. · 2004 [cited by applicant]
US 6739337B2 · Isaza · 2004 [cited by applicant]
US 6852083B2 · Caro et al. · 2005 [cited by applicant]
US 7160250B2 · Lemaire · 2007 [cited by applicant]
US 7231245B2 · Greenwald et al. · 2007 [cited by applicant]
US 7285100B2 · Lemaire · 2007 [cited by applicant]
US 7455643B1 · Li et al. · 2008 [cited by applicant]
US 7547283B2 · Mourad et al. · 2009 [cited by applicant]
US 7496393B2 · Diab et al. · 2009 [cited by applicant]
US 7647185B2 · Tarassenko et al. · 2010 [cited by applicant]
US 7654964B1 · Kroll et al. · 2010 [cited by applicant]
US 7668579B2 · Lynn · 2010 [cited by applicant]
US 7678507B2 · Berkow et al. · 2010 [cited by applicant]
US 7720516B2 · Chin et al. · 2010 [cited by applicant]
US 7865224B2 · Baker, Jr. et al. · 2011 [cited by applicant]
US 7873497B2 · Weber et al. · 2011 [cited by applicant]
US 7887502B2 · Ross et al. · 2011 [cited by applicant]
US 7931559B2 · Baker, Jr. et al. · 2011 [cited by applicant]
US 7957780B2 · Lamego et al. · 2011 [cited by applicant]
US 7976472B2 · Kiani · 2011 [cited by applicant]
US 8019400B2 · Diab et al. · 2011 [cited by applicant]
US 8463346B2 · Kuhn et al. · 2013 [cited by applicant]
US 8512260B2 · Grudic et al. · 2013 [cited by applicant]
US 8641635B2 · Melker et al. · 2014 [cited by applicant]
US 9603534B2 · Gabbay et al. · 2017 [cited by applicant]
US 9757041B2 · Grudic et al. · 2017 [cited by applicant]
US 10226194B2 · Grudic et al. · 2019 [cited by applicant]
US 20010027335A1 · Meyerson et al. · 2001 [cited by applicant]
US 20030060690A1 · Jelliffe et al. · 2003 [cited by applicant]
US 20030125612A1 · Fox et al. · 2003 [cited by applicant]
US 20030130570A1 · Krivitski et al. · 2003 [cited by applicant]
US 20030176931A1 · Pednault et al. · 2003 [cited by applicant]
US 20030200189A1 · Meng et al. · 2003 [cited by applicant]
US 20030212678A1 · Bloom et al. · 2003 [cited by applicant]
US 20040215244A1 · Marcovecchio · 2004 [cited by examiner]
US 20040242972A1 · Adak et al. · 2004 [cited by applicant]
US 20040267145A1 · David et al. · 2004 [cited by applicant]
US 20050015009A1 · Mourad et al. · 2005 [cited by applicant]
US 20050209516A1 · Fraden · 2005 [cited by applicant]
US 20050228298A1 · Banet et al. · 2005 [cited by applicant]
US 20060058691A1 · Kiani · 2006 [cited by applicant]
US 20060106743A1 · Horvitz · 2006 [cited by applicant]
US 20060161403A1 · Jiang et al. · 2006 [cited by applicant]
US 20060166176A1 · Lakin et al. · 2006 [cited by applicant]
US 20060178585A1 · Sharrock · 2006 [cited by applicant]
US 20060195041A1 · Lynn et al. · 2006 [cited by applicant]
US 20060253016A1 · Baker, Jr. et al. · 2006 [cited by applicant]
US 20070015972A1 · Wang et al. · 2007 [cited by applicant]
US 20070032732A1 · Shelley et al. · 2007 [cited by applicant]
US 20070099239A1 · Tabibiazar et al. · 2007 [cited by applicant]
US 20070112275A1 · Cooke et al. · 2007 [cited by applicant]
US 20070213619A1 · Linder · 2007 [cited by applicant]
US 20080039731A1 · McCombie et al. · 2008 [cited by applicant]
US 20080045845A1 · Pfeiffer et al. · 2008 [cited by applicant]
US 20080067132A1 · Ross et al. · 2008 [cited by applicant]
US 20080077023A1 · Campbell et al. · 2008 [cited by applicant]
US 20080097173A1 · Soyemi et al. · 2008 [cited by applicant]
US 20080133434A1 · Asar et al. · 2008 [cited by applicant]
US 20080146890A1 · LeBoeuf et al. · 2008 [cited by applicant]
US 20080146892A1 · LeBoeuf et al. · 2008 [cited by applicant]
US 20080154814A1 · Chaudhury et al. · 2008 [cited by applicant]
US 20080234607A1 · Hunter-Jones et al. · 2008 [cited by applicant]
US 20080294217A1 · Lian et al. · 2008 [cited by applicant]
US 20090005703A1 · Fasciano · 2009 [cited by applicant]
US 20090036754A1 · Pons et al. · 2009 [cited by applicant]
US 20090069647A1 · McNames et al. · 2009 [cited by applicant]
US 20090112106A1 · Zhang · 2009 [cited by applicant]
US 20090143656A1 · Manwaring et al. · 2009 [cited by applicant]
US 20090149724A1 · Mark et al. · 2009 [cited by applicant]
US 20090149751A1 · Mourad et al. · 2009 [cited by applicant]
US 20090204162A1 · Addison et al. · 2009 [cited by applicant]
US 20090264776A1 · Vardy · 2009 [cited by applicant]
US 20090272678A1 · Sornmo et al. · 2009 [cited by applicant]
US 20090281434A1 · Messerges · 2009 [cited by examiner]
US 20090287105A1 · Hirsch · 2009 [cited by applicant]
US 20090292198A1 · Kleiven et al. · 2009 [cited by applicant]
US 20090043222A1 · Chetham · 2009 [cited by applicant]
US 20100016739A1 · Shelley et al. · 2010 [cited by applicant]
US 20100041962A1 · Causevic et al. · 2010 [cited by applicant]
US 20100081942A1 · Huiku · 2010 [cited by examiner]
US 20100094158A1 · Solem et al. · 2010 [cited by applicant]
US 20100160795A1 · Banet et al. · 2010 [cited by applicant]
US 20100191128A1 · Shelley et al. · 2010 [cited by applicant]
US 20100204589A1 · Swoboda et al. · 2010 [cited by applicant]
US 20100249559A1 · Lovejoy · 2010 [cited by applicant]
US 20110077532A1 · Kim et al. · 2011 [cited by applicant]
US 20110112799A1 · Weber et al. · 2011 [cited by applicant]
US 20110152651A1 · Berkow · 2011 [cited by applicant]
US 20110160549A1 · Saroka et al. · 2011 [cited by applicant]
US 20110172545A1 · Grudic et al. · 2011 [cited by applicant]
US 20110201962A1 · Grudic et al. · 2011 [cited by applicant]
US 20110282169A1 · Grudic et al. · 2011 [cited by applicant]
US 20110237914A1 · Lamego et al. · 2011 [cited by applicant]
US 20120123232A1 · Najarian et al. · 2012 [cited by applicant]
US 20120136224A1 · Najarian et al. · 2012 [cited by applicant]
US 20120184840A1 · Najarian et al. · 2012 [cited by applicant]
US 20120245439A1 · André et al. · 2012 [cited by applicant]
US 20120269420A1 · Najarian et al. · 2012 [cited by applicant]
US 20120296219A1 · Chon · 2012 [cited by examiner]
US 20120330117A1 · Grudic et al. · 2012 [cited by applicant]
US 20130041268A1 · Rimoldi et al. · 2013 [cited by applicant]
US 20130218056A1 · Aelen et al. · 2013 [cited by applicant]
US 20130245397A1 · Grudic et al. · 2013 [cited by applicant]
US 20130261468A1 · Semler et al. · 2013 [cited by applicant]
US 20130343585A1 · Bennett et al. · 2013 [cited by applicant]
US 20140073938A1 · Rodriguez-Llorente et al. · 2014 [cited by applicant]
US 20140107437A1 · Pinsky · 2014 [cited by applicant]
US 20140236053A1 · Walker et al. · 2014 [cited by applicant]
US 20150065826A1 · Mulligan et al. · 2015 [cited by applicant]
US 20150073723A1 · Mulligan et al. · 2015 [cited by applicant]
US 20150141769A1 · Mulligan et al. · 2015 [cited by applicant]
US 20160015284A1 · Grudic et al. · 2016 [cited by applicant]
US 20160038042A1 · Mulligan et al. · 2016 [cited by applicant]
US 20160162786A1 · Grudic et al. · 2016 [cited by applicant]
US 20160354039A1 · Soto et al. · 2016 [cited by applicant]
US 20160374625A1 · Mulligan et al. · 2016 [cited by applicant]
US 20170007139A9 · Grudic et al. · 2017 [cited by applicant]
US 20170215016A1 · Dohmen et al. · 2017 [cited by applicant]
US 20170258329A1 · Marsh · 2017 [cited by applicant]
US 20170303799A1 · Grudic et al. · 2017 [cited by applicant]
US 20170347177A1 · Masaki · 2017 [cited by applicant]
US 20180214028A1 · Zhang et al. · 2018 [cited by applicant]
US 20200205734A1 · Mulligan et al. · 2020 [cited by applicant]
US 20200205747A1 · Mulligan et al. · 2020 [cited by applicant]
CA 2871608 · 2021 [cited by applicant]
EP 3468457 · 2019 [cited by applicant]
WO WO2003077854A2 · 2003 [cited by applicant]
WO WO2003091421A3 · 2003 [cited by applicant]
WO WO2005055825A1 · 2005 [cited by applicant]
WO WO2005112756A1 · 2005 [cited by applicant]
WO WO2007011565A1 · 2007 [cited by applicant]
WO WO2007098957A1 · 2007 [cited by applicant]
WO WO2007117570A2 · 2007 [cited by applicant]
WO WO2007149533A2 · 2007 [cited by applicant]
WO WO2010009735A2 · 2010 [cited by applicant]
WO WO2010053743A1 · 2010 [cited by applicant]
WO WO2010117572A2 · 2010 [cited by applicant]
WO WO2011002904A2 · 2011 [cited by applicant]
WO WO2011050066A2 · 2011 [cited by applicant]
WO WO2011103102A1 · 2011 [cited by applicant]
WO WO2011109734A1 · 2011 [cited by applicant]
WO WO2012054880A2 · 2012 [cited by applicant]
WO WO2012166568A3 · 2012 [cited by applicant]
WO WO2013016212A1 · 2013 [cited by applicant]
WO WO2014149981A1 · 2014 [cited by applicant]
WO WO2015042484A1 · 2015 [cited by applicant]
WO WO2015069940A1 · 2015 [cited by applicant]
WO WO2015073909A1 · 2015 [cited by applicant]
WO WO2015073910A1 · 2015 [cited by applicant]
WO WO2016061542A1 · 2016 [cited by applicant]
WO WO2016061545A1 · 2016 [cited by applicant]
WO WO2017044868A1 · 2017 [cited by applicant]
WO WO2017218431A1 · 2017 [cited by applicant]
U.S. Appl. No. 14/542,426, Final Office Action dated Sep. 26, 2016, 25 pages. [cited by applicant]
Intravenous Therapy (Wikipedia) Accessed on: Sep. 27, 2016, 12 pages. [cited by applicant]
U.S. Appl. No. 13/554,483, Final Office Action dated Oct. 7, 2016, 28 pages. [cited by applicant]
International Search Report and Written Opinion prepared by the U.S. Patent and Trademark Office as International Searching Authority for PCT International Patent Application No. PCT/US09/62119, mailed Feb. 3, 2010, 5 p… [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT/US2009/062119, mailed May 12, 2011, 6 pages. [cited by applicant]
Decision to Grant, Apr. 23, 2015 for EP 09825222.4, 3 pages. [cited by applicant]
European Search Report, Jun. 15, 2012 for EP 09825222.4, 10 pages. [cited by applicant]
Procopio et al (2008) Intelligent Robots And Systems IEEE/RSJ International Conference, pp. 620-627, “Learning in 1-14 dynamic environments with Ensemble Selection for autonomous outdoor robot navigation”. [cited by applicant]
Shoemaker, et al (2001) CHEST, 120(2):528-538, “Outcome Prediction of Emergency Patients by Noninvasive Hemodynamic Monitoring”. [cited by applicant]
Supplemental European Search Report, Jul. 3, 2012 for EP 09825222.4, 1 page. [cited by applicant]
U.S. Appl. No. 13/126,727, NonFinal Office Action dated Sep. 11, 2014; 58 pages. [cited by applicant]
U.S. Appl. No. 13/028,140, NonFinal Office Action dated Nov. 13, 2012; 27 pages. [cited by applicant]
U.S. Appl. No. 13/028,140, Notice of Allowance dated Feb. 22, 2013; 22 pages. [cited by applicant]
U.S. Appl. No. 13/889,513, NonFinal Office Action mailed Jun. 15, 2015, 27 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT/US11/24938, mailed Aug. 30, 2012, 7 pages. [cited by applicant]
International Search Report and Written Opinion prepared by the U.S. Patent and Trademark Office as International Searching Authority for PCT International Patent Application No. PCT/US2011/24938, mailed Jun. 7, 2011, 1… [cited by applicant]
Supplemental European Search Report, Jun. 21, 2013 for EP 11745124.5, 7 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, NonFinal Office Action dated May 23, 2014; 27 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, NonFinal Office Action dated Dec. 22, 2014; 14 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT/US11/27237, mailed Sep. 13, 2012, 10 pages. [cited by applicant]
International Search Report and Written Opinion prepared by the U.S. Patent and Trademark Office as International Searching Authority for PCT International Patent Application No. PCT/US2011/027237, mailed May 27, 2011, … [cited by applicant]
Cooke et al. (2004) Journal of Applied Physiology 96(4):1249-1261, “Lower body negative pressure as a model to study progression to acute hemorrhagic shock in humans”. [cited by applicant]
Extended European Search Report, Oct. 18, 2013 for EP11751440.6, 7 pages. [cited by applicant]
Lambert et al. (2007) ACTA Anesthesiologica Scandinavica 51(4):415-425, “Does a positive 1-27 end-expiratory pressure-induced reduction in stroke volume indicate preload responsiveness? An experimental study”. [cited by applicant]
Ryan et al. (2008) Journal f Applied Physiology 104(5):1402-1409, “Breathing through an inspiratory threshold device improves stroke volume during central hypovolemia in humans”. [cited by applicant]
Supplemental Extended European Search Report, Nov. 6, 2013 for EP11751440.6, 8 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT International Patent Application No. PCT/US12/047659, mailed Feb. 6, 2014, 10 pages. [cited by applicant]
International Search Report and Written Opinion prepared by the U.S. International Searching Authority for PCT International Patent Application No. PCT/US12/047659, mailed Oct. 12, 2012, 16 pages. [cited by applicant]
Extended European Search Report for EP 12816832.5, mailed Oct. 6, 2014, 9 pages. [cited by applicant]
International Search Report and Written Opinion prepared by the Korean Intellectual Property Office as International Searching Authority for PCT International Patent Application No. PCT/US2014/064413, mailed Feb. 12, 20… [cited by applicant]
International Search Report and Written Opinion prepared by the Korean Intellectual Property Office as International Searching Authority for PCT International Patent Application No. PCT/US2014/065818, mailed Feb. 26, 20… [cited by applicant]
International Search Report and Written Opinion prepared by the Korean Intellectual Property Office as International Searching Authority for PCT International Patent Application No. PCT/US2014/065820, mailed Feb. 26, 20… [cited by applicant]
Berkow (Aug. 2010) Intelomed, Inc., “CVInsight,” 14 pages. [cited by applicant]
Berkow (Jan. 2012) 510(K) Summary, “CVInsight,” 9 pages. [cited by applicant]
Najarian (2012) VCU School of Engineering ResearchReport, vol. 5, p. 3. [cited by applicant]
U.S. Appl. No. 13/126,727, Final Rejection dated Aug. 27, 2015; 33 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, Final Rejection dated Sep. 15, 2015; 19 pages. [cited by applicant]
Canadian Patent Application No. 2,775,675, NonFinalOA dated Dec. 9, 2015; 3 pages. [cited by applicant]
International Search Report and Written Opinion prepared by the Korean Intellectual Property Office as International Searching Authority for PCT International Patent Application No. PCT/US2015/056078, mailed Jan. 25, 20… [cited by applicant]
International Search Report and Written Opinion prepared by the Korean Intellectual Property Office as International Searching Authority for PCT International Patent Application No. PCT/US2015/56074, mailed Jan. 29, 201… [cited by applicant]
Convertino, Victor, “Estimation of individual-specific progression to impending cardiovascular instability using arterial waveforms,” Journal of Applied Physiology, Oct. 15, 2013, vol. 115, No. 8, pp. 1196-1202. [cited by applicant]
U.S. Appl. No. 14/542,426, Non-Final Office Action dated Feb. 26, 2016; 25 pages. [cited by applicant]
U.S. Appl. No. 13/554,483, Non-Final Office Action dated Mar. 22, 2016; 41 pages. [cited by applicant]
EP11751440.6, Office Action 94(3) dated Feb. 24, 2016, 5 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, Non-final Office Action dated Apr. 22, 2016, 15 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT International Patent Application No. PCT/US14/064413, mailed May 19, 2016, 10 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT International Patent Application No. PCT/US14/65818, mailed May 26, 2016, 11 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT International Patent Application No. PCT/US14/65820, mailed May 26, 2016, 11 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT/US15/56074, mailed Apr. 27, 2017, 10 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT/US15/56078, mailed Apr. 27, 2017, 7 pages. [cited by applicant]
Extended European Search Report for EP14862697.1, dated Jun. 14, 2017; 8 pages. [cited by applicant]
U.S. Appl. No. 14/885,888, Final Office Action dated Jul. 27, 2017, 29 pages. [cited by applicant]
EP 11745124.5, Office Action 94(3) dated Jul. 31, 2017, 6 pages. [cited by applicant]
Kotsiantis (2007) Department of Computer Science and Technology, “Supervised Matchine Learning: A Review of Classification Techniques,” 20 pages. [cited by applicant]
Wu et al, (2009) World Congress on Computer Science and Information Enginerring, “Time Series Mining Approach for Noninvasive Intracranial Pressure Assessment: an Investigation of Different Regularization Techniques,” 5… [cited by applicant]
Extended European Search Report, Jun. 7, 2017 for EP14862921.5, 8 pages. [cited by applicant]
Extended European Search Report, Jun. 20, 2017 for EP14859538.2, 8 pages. [cited by applicant]
International Search Report and Written Opinion prepared by the Korean Intellectual Property Office as International Searching Authority for PCT International Patent Application No. PCT/US2017/037067, mailed Aug. 18, 20… [cited by applicant]
International Search Report and Written Opinion prepared by the Korean Intellectual Property Office as International Searching Authority for PCT International Patent Application No. PCT/US2016/051130, mailed Dec. 8, 201… [cited by applicant]
U.S. Appl. No. 14/535,171, NonFinalOA dated Dec. 16, 2016, 37 pages. [cited by applicant]
U.S. Appl. No. 14/885,888, NonFinalOA dated Dec. 16, 2016, 35 pages. [cited by applicant]
Nadler et al. 2014, Shock 42(2): 93-98, “The Value of Noninvasive Measurement of the Compensatory Reserve Index in Monitoring and Triage of Patients Experiencing Minimal Blood Loss”. [cited by applicant]
Nadler et al. 2017, Annals of Medicine and Surgery, “The approximated cardiovascular reserve index complies with haemorrhage related hemodynamic deterioration pattern: A swine exsanguination model” 7 pages. [cited by applicant]
Canadian Patent Application No. 2,775,675, NonFinalOA dated Nov. 9, 2016; 4 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, NonFinalOA dated Mar. 7, 2017, 21 pages. [cited by applicant]
U.S. Appl. No. 13/554,483, Notice of Allowance dated Mar. 7, 2017, 39 pages. [cited by applicant]
U.S. Appl. No. 13/889,513, Final Rejection dated Apr. 11, 2017; 51 pages. [cited by applicant]
Schmidt et al. (1997) Stroke, “Noninvasive Prediction of Intracranial Pressure Curves Using Transcranial Doppler Ultrasonography and Blood Pressure Curves,” 22 pages. [cited by applicant]
U.S. Appl. No. 14/542,426, Non-Final Office Action dated May 5, 2017; 17 pages. [cited by applicant]
U.S. Appl. No. 14/542,423, NonFinal Office Action dated May 8, 2017; 35 pages. [cited by applicant]
U.S. Appl. No. 14/535,171, Final Office Action dated Nov. 16, 2017, 30 pages. [cited by applicant]
U.S. Appl. No. 13/889,513, NonFinal Office Action dated Dec. 1, 2017, 51 pages. [cited by applicant]
U.S. Appl. No. 14/867,938, NonFinal Office Action dated Dec. 8, 2017, 27 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, NonFinal Office Action dated Dec. 15, 2017, 21 pages. [cited by applicant]
Canadian Patent Application No. 2,775,675, NonFinalOA dated Sep. 27, 2017; 4 pages. [cited by applicant]
U.S. Appl. No. 14/542,426, Non-Final Office Action dated Feb. 1, 2018, 19 pages. [cited by applicant]
U.S. Appl. No. 14/542,423, NonFinal Office Action dated Feb. 5, 2018, 24 pages. [cited by applicant]
Canadian Patent Application No. 2,871,608, NonFinalOA dated Jan. 25, 2018; 5 pages. [cited by applicant]
U.S. Appl. No. 14/885,888, NonFinal Office Action dated Mar. 15, 2018, 11 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT/US2009/062119, mailed Mar. 22, 2018, 9 pages. [cited by applicant]
U.S. Appl. No. 15/649,411, NonFinalOA dated Apr. 5, 2018, 23 pages. [cited by applicant]
Extended European Search Report for EP15850241.9, dated Apr. 5, 2018; 8 pages. [cited by applicant]
U.S. Appl. No. 15/007,489, NonFinal Office Action dated Jun. 13, 2018; 48 pages. [cited by applicant]
U.S. Patent Application No. 14/535,1711, NonFinalOA dated Aug. 9, 2018, 23 pages. [cited by applicant]
U.S. Appl. No. 14/867,938, Notice of Allowance dated Sep. 6, 2018; 17 pages. [cited by applicant]
U.S. Appl. No. 13/889,513, Final Office Action dated Sep. 20, 2018, 25 pages. [cited by applicant]
U.S. Appl. No. 14/542,426, Final Office Action dated Sep. 27, 2018, 11 pages. [cited by applicant]
U.S. Appl. No. 14/885,888, Final Office Action dated Sep. 28, 2018, 7 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, Final Office Action dated Oct. 3, 2018, 9 pages U.S. Appl. No. 15/261,661, NonFinal Office Action dated Oct. 12, 2018, 38 pages. [cited by applicant]
Canadian Patent Application No. 2,871,608, NonFinalOA dated Nov. 22, 2018, 3 pages. [cited by applicant]
European Patent Application No. 12816832.5, NonFinalOA dated Oct. 12, 2018, 4 pages. [cited by applicant]
International Preliminary Report on Patentability prepared by the International Bureau for PCT International Patent Application No. PCT/US2017/037067, mailed Dec. 27, 2018, 13 pages. [cited by applicant]
U.S. Appl. No. 14/542,423, NonFinal Office Action dated Dec. 28, 2018, 18 pages. [cited by applicant]
Extended European Search Report for EP16845202.7, dated Feb. 1, 2019; 6 pages. [cited by applicant]
Moulton et al. (2013) Trauma Acute Care Surg 75(6):1053-1059, “Running on empty? The Compensatory Reserve Index”. [cited by applicant]
Poh et al. (2014) Experimental Physiology, 1421-1426, “Respiratory Pump Contributes to Increased Physiological Reserve for Compensation During Simulated Haemorrhage”. [cited by applicant]
EPO Communication pursuant to Rules 161(2) and 162 EPC dated Feb. 1, 2019, 4 pages. [cited by applicant]
Extended European Search Report Written Opinion for EP16845202.7, dated Mar. 11, 2019, 8 pages. [cited by applicant]
EPO Communication pursuant to Rule 70(2) and 70(a)(2) EPC, dated Mar. 13, 2019, 1 page. [cited by applicant]
U.S. Appl. No. 15/007,489, Final Office Action dated Mar. 20, 2019, 36 pages. [cited by applicant]
U.S. Appl. No. 15/649,411, Non-Final OA dated Apr. 2, 2019, 24 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, Non-Final OA dated Apr. 4, 2019, 15 pages. [cited by applicant]
U.S. Appl. No. 14/542,426, Non-Final OA dated Apr. 5, 2019, 9 pages. [cited by applicant]
U.S. Appl. No. 15/261,661, Final OA dated Apr. 5, 2019, 19 pages. [cited by applicant]
U.S. Appl. No. 13/889,513, Restriction Requirement dated Apr. 12, 2019, 9 pages. [cited by applicant]
U.S. Appl. No. 14/885,888, Non-Final Office Action dated May 15, 2019, 21 pages. [cited by applicant]
U.S. Appl. No. 14/535,171, Final OA dated Jul. 3, 2019, 20 pages. [cited by applicant]
U.S. Appl. No. 14/542,423, Non-Final Office Action dated Jul. 9, 2019, 17 pages. [cited by applicant]
U.S. Appl. No. 15/620,701, Non-Final Office Action dated Aug. 12, 2019, 27 pages. [cited by applicant]
Japan Patent Application No. 2017-539521 Office Action, dated Sep. 5, 2019, 7 pages. [cited by applicant]
EP Application No. 15850241.9, EP Examination Report, dated Oct. 14, 2019, 6 pages. [cited by applicant]
U.S. Appl. No. 16/726,334, filed Dec. 24, 2019 by Mulligan et al. and entitled “Device-Based Maneuver and Activity State-Based Physiologic Status Monitoring,” 89 pages. [cited by applicant]
U.S. Appl. No. 16/726,337, filed Dec. 24, 2019 by Mulligan et al. and entitled “Ear-Based Physiological State Monitoring” 78 pages. [cited by applicant]
U.S. Appl. No. 15/649,411, Final OA dated Dec. 23, 2019, 19 pages. [cited by applicant]
U.S. Appl. No. 14/885,888, Final Office Action dated Jan. 2, 2020, 2019, 21 pages. [cited by applicant]
U.S. Appl. No. 14/542,426, Final OA dated Dec. 20, 2019, 19 pages. [cited by applicant]
U.S. Appl. No. 15/261,661, Non-Final Rejection dated Jan. 16, 2020, 20 pages. [cited by applicant]
U.S. Appl. No. 14/535,171, Non-Final Rejection dated Jan. 23, 2020, 20 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, Final Rejection dated Jan. 27, 2020; 10 pages. [cited by applicant]
U.S. Appl. No. 13/889,513, Non-Final OA, mailed on Jan. 28, 2020, 27 pages. [cited by applicant]
U.S. Appl. No. 14/542,423, Final Office Action dated May 18, 2020, 21 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, Final Rejection, dated Jan. 7, 2021; 30 pages. [cited by applicant]
U.S. Appl. No. 14/885,888, Final Office Action dated Mar. 30, 2021, 25 pages. [cited by applicant]
U.S. Appl. No. 13/889,513, Notice of Abandonment, dated Sep. 25, 2020, 2 pages. [cited by applicant]
U.S. Appl. No. 14/535,171, Non-Final Office Action dated Oct. 5, 2020, 21 pages. [cited by applicant]
U.S. Appl. No. 14/542,423, Non-Final Office Action dated Oct. 6, 2020, 21 pages. [cited by applicant]
U.S. Appl. No. 15/620,701, Non-Final Office Action dated Oct. 21, 2020, 20 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, Non-Final Rejection dated Jun. 12, 2020; 29 pages. [cited by applicant]
U.S. Appl. No. 15/620,701, Final Office Action dated Jun. 22, 2020, 25 pages. [cited by applicant]
EPO Communication pursuant to Rules 71(3) dated Jun. 23, 2020, 57 pages. [cited by applicant]
U.S. Appl. No. 15/649,411, Non-Final Office Action, dated Jul. 29, 11 pages. [cited by applicant]
U.S. Appl. No. 14/885,888, Non-Final Office Action dated Aug. 6, 2020, 2019, 21 pages. [cited by applicant]
U.S. Appl. No. 14/542,426, Non-Final Office Action dated Aug. 6, 2020, 2019, 19 pages. [cited by applicant]
U.S. Appl. No. 15/261,661, Non-Final Rejection dated Sep. 3, 2020, 22 pages. [cited by applicant]
U.S. Appl. No. 16/726,337, Final Office Action dated Sep. 7, 2021, 68 pages. [cited by applicant]
U.S. Appl. No. 15/620,701, Final Office Action dated Oct. 26, 2021, 22 pages. [cited by applicant]
U.S. Appl. No. 16/726,337, Non-Final Office Action dated May 17, 2021; 79 pages. [cited by applicant]
U.S. Appl. No. 15/261,661, Final Office Action dated May 19, 2021, 25 pages. [cited by applicant]
U.S. Appl. No. 14/535,171, Final Office Action dated May 19, 2021, 22 pages. [cited by applicant]
U.S. Appl. No. 14/542,423, Final Office Action dated May 19, 2021, 21 pages. [cited by applicant]
U.S. Appl. No. 15/649,411, Non-Final Office Action, dated May 19, 2021, 21 pages. [cited by applicant]
U.S. Appl. No. 14/542,426, Final Office Action dated Jun. 1, 2021, 20 pages. [cited by applicant]
U.S. Appl. No. 15/620,701, Non-Final Office Action dated Jun. 6, 2021, 22 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, Non-Final Office Action dated Jul. 16, 2021; 32 pages. [cited by applicant]
U.S. Appl. No. 14/885,888, Non-Final Office Action, dated Dec. 24, 2021, 28 pages. [cited by applicant]
U.S. Appl. No. 13/041,006, Final Office Action, dated Jan. 27, 2022; 32 pages. [cited by applicant]
U.S. Appl. No. 15/649,411, Notice of Allowance, dated Feb. 2, 2022, 30 pages. [cited by applicant]
U.S. Appl. No. 14/535,171, Notice of Allowance, dated Feb. 9, 2022, 30 pages. [cited by applicant]
U.S. Appl. No. 15/261,661, Notice of Allowance, dated Mar. 10, 2022; 48 pages. [cited by applicant]
U.S. Appl. No. 14/542,423, Notice of Allowance, dated Mar. 16, 2022; 29 pages. [cited by applicant]